Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
ABT MDT SYK ISRG Index Choice Plastics Communication Drugs 
United States  USA  |  Check Insiders


Processing
Collecting data for NXTM

Nxstage quote and profile

 
 Companies |  Insiders  | Dashboard  
     
13.07
  
STOCK
0.24  Macroaxis: 1.87 Up   1.87%  
Year To Date
10.1517.7
Trading Day 
12.7813.09
May 19 2013 

Diversification Suggestion

Use Nxstage to enhance returns of your portfolios. The stock experiences large bullish trend
Analyze Nxstage Medical Trend or Check current 30 days Nxstage correlation with market (S&P 500)
1 Month Beta 2.53  
Highest Price:  
Lowest Price:  
13.07  
10.68  
May 17 2013 
May 01 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Nxstage will likely underperform.
Nxstage Medical Inc Large BetaNxstage Medical Beta Legend
NXTM United States Nasdaq
Nxstage Medical Inc
Healthcare
Medical Appliances and Equipment
http://www.nxstage.com
Contact Number: 978. 687. 4700
Currency: USD - US Dollar
Traded on NASDAQ
    
Current Valuation549.05 M
Shares Outstanding59.35 M
Number of Shares Shorted2.94 M
Revenue242.13 M
 thisGreen NXTM NXTM agains markets  1.87 % Macroaxis: change 1.87 Moved Up  
 
 United States Russel   1.11 % Macroaxis: change 1.11 Moved Up  
 
 United States SP 500   1.03 % Macroaxis: change 1.03 Moved Up  
 
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States NYSE   0.92 % Macroaxis: 0.92 Moved Up  
 
Compare to Competition Get Alpha   Get Advice

Nxstage Leadership

Jeffrey Burbank CEO and President and Director
Philippe Chambon Independent Chairman of the Board, MBA
Thomas Shea Senior Vice President - Manufacturing Operations
Joseph Turk President of North American Operations

Nxstage Price and Market Media

The median price of Nxstage for the period between Fri, Apr 19, 2013 and Sun, May 19, 2013 is 11.66 with a coefficient of variation of 7.27. The daily time series for the period is distributed with a sample standard deviation of 0.85, arithmetic mean of 11.73, and mean deviation of 0.76. The Stock received substential amount of media coverage during this period.
Nxstage         Market
Price Growth (%)
 
1
NxStage Medical Inc Announces Resignation Of Philippe O. Cha...04/26/2013Macroaxis: Reuters News
2
Nephrology And Urology Devices Market Dialysis Equipment Lit...05/01/2013Macroaxis: News
3
Nxstage Medical Posts Quarterly Earnings Hits Estimates05/03/2013Macroaxis: News
4
Nxstage Medical Given New 12.00 Price Target at Feltl and Co...05/08/2013Macroaxis: News
5
The World Market for Dialysis Equipment and Services United ...05/10/2013Macroaxis: News

Nxstage Summary

Nxstage Medical Inc [NXTM] is traded on NASDAQ in USA. It is located in Nxstage Medical, Inc.Lawrence, MA and employs 2,700 people. The company currently falls under 'Small-Cap' category with current market capitalization of 643.93 M. Nxstage Medical Inc conducts business under Healthcare sector and is part of Medical Appliances and Equipment industry. This company has 59.35 M outstanding shares of which 2.94 M shares are now shorted by private and institutional investors with about 10.1 trading days to cover.
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets solutions for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. more
Past Market
Over 30
Days
26
Out Of
100
 
Chance of
Less
Than
%
 
Follow Nxstage with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Nxstage to your reader
 

Nxstage Research Report

Nxstage vs. Abbott

Correlation analysis and fundamentals comparison between Nxstage Medical and Abbott Laboratories

Nxstage Executives

Robert Brown CFO, Principal Accounting Officer, Sr. VP and Treasurer, MBA

Nxstage Directors

Barry Straube Independent Director
Daniel Giannini Independent Director
David Utterberg Director
Jean Mixer Director
Reid Perper Independent Director

Nxstage Management

Kristen Esq VP of Investor Relations

Nxstage Fundamentals

Price to Book vs EBITDA
Working Capital vs Price to Sales
Price to Book vs Total Debt
Beta vs Price to Sales

Nxstage vs Competition

Nxstage vs. Abbott Laboratories
Nxstage vs. Medtronic Inc
Nxstage vs. Stryker Corporation
Nxstage vs. Intuitive Surgical Inc
Nxstage vs. Zimmer Holdings Inc
Nxstage vs. Boston Scientific Corporation
Nxstage vs. St Jude Medical Inc
Nxstage vs. Smith Nephew plc
Nxstage vs. Edwards Lifesciences Corp
Nxstage vs. Varian Medical Systems Inc

Nxstage May 19 2013 Opportunity Range

Downside Deviation2.25
Information Ratio0.301
Maximum Drawdown5.69
Value At Risk(0.65)
Potential Upside4.2

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium